Health Catalyst Inc (HCAT) Stock Analysis

Health Catalyst Inc (HCAT) is a publicly traded company in the HEALTHCARE sector. It trades at $1.35, carries a market capitalization of $102.71M. This page summarizes the public market data, fundamentals, and frequently asked questions for HCAT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - HEALTH INFORMATION SERVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Health Catalyst Inc currently has a Neutral sentiment score of 0.06.

About Health Catalyst Inc

Health Catalyst, Inc. (HCAT) is a leading provider of data and analytics technology alongside services tailored for healthcare organizations, empowering them to drive operational improvements and enhance patient outcomes. Headquartered in South Jordan, Utah, the company leverages its robust data platform and analytics capabilities to facilitate data-driven decision-making across various healthcare sectors. With a focus on improving the quality and efficiency of healthcare delivery, Health Cat...

GNG Research Analysis

GNG Research scores Health Catalyst Inc (HCAT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for HCAT.

Frequently Asked Questions

Does HCAT pay dividends?

Health Catalyst Inc (HCAT) does not currently pay a regular dividend.

What is HCAT's market cap?

Health Catalyst Inc (HCAT) has a market capitalization of $102.71M with a current stock price of $1.35.